Senior Director, SEC Reporting & SOX — Hybrid (Biotech)

Klein Hersh International

Boston (MA)

Hybrid

USD 180,000 - 240,000

Full time

14 days+

A complete application in a minute

Tailored resume and cover letter, ready to send.

Get past ATS filters

Job summary

Klein Hersh International is seeking a highly capable SEC Reporting & SOX professional to support the preparation and filing of external financial reports for a clinical-stage oncology company.

The role encompasses SEC filings, SOX compliance, technical accounting, equity administration, and audit support, with a hybrid Boston work arrangement. This position requires a CPA and 8+ years in sophisticated accounting work.

Qualifications

  • Bachelor’s degree in Accounting and CPA license.
  • 8+ years of progressive accounting experience.
  • Hands-on SEC filings experience (10-K/10-Q) and technical accounting research.
  • Experience supporting SOX compliance, including control execution, documentation, and testing.
  • Strong knowledge of U.S. GAAP and SEC reporting requirements.
  • Life sciences/pharma industry experience preferred.
  • Familiarity with DFIN Active Disclosure, NetSuite, and XBRL tagging.

Responsibilities

  • Lead the preparation of SEC reports (10-K, 10-Q, 8-K) for review by the Corporate Controller.
  • Draft financial statements, footnotes, MD&A, and disclosures per SEC regulations and U.S. GAAP.
  • Coordinate quarterly and annual reporting with cross-functional inputs and schedules.
  • Assist with XBRL tagging and interactions with external providers.
  • Prepare earnings releases and support investor relations materials.
  • Support proxy filings.

Skills

SEC reporting
SOX compliance
Technical accounting
Project management
Communication
Independent work

Education

Bachelor’s degree in Accounting
CPA

Tools

DFIN Active Disclosure
NetSuite
XBRL tagging

Job description

Klein Hersh International is seeking a highly capable SEC Reporting & SOX professional to support the preparation and filing of external financial reports for a clinical-stage oncology company.

The role encompasses SEC filings, SOX compliance, technical accounting, equity administration, and audit support, with a hybrid Boston work arrangement. This position requires a CPA and 8+ years in sophisticated accounting work.

Get your free, confidential resume review.

or drag and drop your file here.

Similar jobs

Similar jobs worth comparing

Senior Director, SEC Reporting & SOX Compliance - Oncology FinOps
Senior Director, SEC Reporting & SOX Compliance - Oncology FinOps

Klein Hersh • Boston (MA)

Hybrid
USD 180,000 - 230,000
Senior Director, SEC Reporting & SOX Compliance
Senior Director, SEC Reporting & SOX Compliance

Klein Hersh International • Boston (MA)

Hybrid
USD 180,000 - 240,000
Senior Director, SEC Reporting & SOX Compliance
Senior Director, SEC Reporting & SOX Compliance

Klein Hersh • Boston (MA)

Hybrid
USD 180,000 - 230,000
Senior SEC Reporting & Tech Accounting Analyst — Hybrid
Senior SEC Reporting & Tech Accounting Analyst — Hybrid

BridgeBio Inc. • San Francisco (CA)

Hybrid
USD 135,000 - 155,000
Market-leading compensation
401(k) with employer match
Employee Stock Purchase Program (ESPP)
+3
Senior SEC Reporting & Tech Accounting - Hybrid
Senior SEC Reporting & Tech Accounting - Hybrid

BridgeBio Pharma • Palo Alto (CA), San Francisco (CA)

Hybrid
USD 135,000 - 155,000
Market-leading compensation
401(k) with employer match
Hybrid work model
Sr. Mgr, SEC Reporting & Technical Accounting
Sr. Mgr, SEC Reporting & Technical Accounting

CorMedix Therapeutics • Chicago (IL)

On-site
USD 150,000 - 190,000
SEC Reporting & Equity Accounting Manager
SEC Reporting & Equity Accounting Manager

Neurocrine Biosciences • San Diego (CA)

Hybrid
USD 120,000 - 180,000
Senior SEC & Technical Accounting Manager (Hybrid, Equity)
Senior SEC & Technical Accounting Manager (Hybrid, Equity)

KBW Financial Staffing & Recruiting • Boston (MA)

Hybrid
USD 130,000 - 160,000
Bonus
Equity
Hybrid Senior SEC Reporting Accountant
Hybrid Senior SEC Reporting Accountant

Collegium Pharmaceutical, Inc. • Stoughton (MA)

Hybrid
USD 95,000 - 115,000
SEC Reporting, Sr. Manager
SEC Reporting, Sr. Manager

WatsonBarron Group • Princeton (NJ)

Hybrid
USD 170,000 - 200,000